Asymptomatic carotid plaque rupture with unexpected thrombosis over a non-canonical vulnerable lesion

Atherosclerosis

Volumn 218, Issue 2, 2011, Pages 356-362

  Mauriello, Alessandro ^a   Servadei, Francesca ^a   Sangiorgi, Giuseppe ^a   Anemona, Lucia ^a   Giacobbi, Erica ^a   Liotti, Doriana ^a   Spagnoli, Luigi Giusto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Asymptomatics; Carotid; Pathology; Thrombosis

Indexed keywords

AGED; ARTICLE; CAROTID ARTERY THROMBOSIS; CAROTID ATHEROSCLEROSIS; CLINICAL FEATURE; DISEASE PREDISPOSITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE;

ACUTE DISEASE; AGED; ATHEROSCLEROSIS; CAROTID ARTERIES; DISEASE PROGRESSION; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; INFLAMMATION; ISCHEMIA; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NECROSIS; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; THROMBOSIS;

EID: 80053284584     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.06.056     Document Type: Article

References (34)

1. Spagnoli L.G., Mauriello A., Sangiorgi G., et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004, 292:1845-1852.
2. Redgrave J.N., Lovett J.K., Gallagher P.J., Rothwell P.M. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006, 113:2320-2328.
3. Virmani R., Ladich E.R., Burke A.P., Kolodgie F.D. Histopathology of carotid atherosclerotic disease. Neurosurgery 2006, 59:S219-S227. discussion S213.
4. Golledge J., Greenhalgh R.M., Davies A.H. The symptomatic carotid plaque. Stroke 2000, 31:774-781.
5. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006, 37:577-617.
6. Goldstein L.B., Adams R., Alberts M.J., et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006, 37:1583-1633.
7. Takaya N., Yuan C., Chu B., et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke 2006, 37:818-823.
8. Chu B., Ferguson M.S., Chen H., et al. Magnetic resonance imaging features of the disruption-prone and the disrupted carotid plaque. JACC Cardiovasc Imag 2009, 2:883-896.
9. Saam T., Cai J., Ma L., et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology 2006, 240:464-472.
10. Fabiano S., Mancino S., Stefanini M., et al. High-resolution multicontrast-weighted MR imaging from human carotid endarterectomy specimens to assess carotid plaque components. Eur Radiol 2008, 18:2912-2921.
11. Coli S., Magnoni M., Sangiorgi G., et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol 2008, 52:223-230.
12. Underhill H.R., Hatsukami T.S., Fayad Z.A., Fuster V., Yuan C. MRI of carotid atherosclerosis: clinical implications and future directions. Nat Rev Cardiol 2010, 7:165-173.
13. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation 1995, 92:657-671.
14. Virmani R., Kolodgie F.D., Burke A.P., Farb A., Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000, 20:1262-1275.
15. Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54:2129-2138.
16. Mauriello A., Sangiorgi G.M., Virmani R., et al. A pathobiologic link between risk factors profile and morphological markers of carotid instability. Atherosclerosis 2010, 208:572-580.
17. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
18. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
19. Vergara I.A., Norambuena T., Ferrada E., Slater A.W., Melo F. StAR: a simple tool for the statistical comparison of ROC curves. BMC Bioinformatics 2008, 9:265.
20. Akobeng A.K., Thomas A.G. Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2007, [CD005984].
21. Mantovani A., Sica A., Sozzani S., et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
22. Stoger J.L., Goossens P., de Winther M.P. Macrophage heterogeneity: relevance and functional implications in atherosclerosis. Curr Vasc Pharmacol 2010, 8:233-248.
23. Fabriek B.O., Dijkstra C.D., van den Berg T.K. The macrophage scavenger receptor CD163. Immunobiology 2005, 210:153-160.
24. Kovanen P.T. Mast cells: multipotent local effector cells in atherothrombosis. Immunol Rev 2007, 217:105-122.
25. Moreno P.R., Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol 2004, 44:2293-2300.
26. Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004, 24:816-823.
27. Adams M.R., Kinlay S., Blake G.J., et al. Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes. Annu Rev Med 2000, 51:149-167.
28. Barter P.J., Nicholls S., Rye K.A., Anantharamaiah G.M., Navab M., Fogelman A.M. Antiinflammatory properties of HDL. Circ Res 2004, 95:764-772.
29. Schiffrin E.L. Beyond blood pressure: the endothelium and atherosclerosis progression. Am J Hypertens 2002, 15:S115-S122.
30. Spagnoli L.G., Mauriello A., Palmieri G., et al. Relationships between risk factors and morphological patterns of human carotid atherosclerotic plaques. A multivariate discriminant analysis. Atherosclerosis 1994, 108:39-60.
31. Li Z.Y., Howarth S.P., Tang T., Gillard J.H. How critical is fibrous cap thickness to carotid plaque stability? A flow-plaque interaction model. Stroke 2006, 37:1195-1199.
32. Davies P.F. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med 2009, 6:16-26.
33. Kwee R.M. Systematic review on the association between calcification in carotid plaques and clinical ischemic symptoms. J Vasc Surg 2010, 51:1015-1025.
34. Wahlgren C.M., Zheng W., Shaalan W., Tang J., Bassiouny H.S. Human carotid plaque calcification and vulnerability. Relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology. Cerebrovasc Dis 2009, 27:193-200.